Prevalence of Airway Obstruction Assessed by Lung Function Questionnaire
Authors:
- Barbara P. YawnBYBarbara P. Yawn
- David M. ManninoDMDavid M. Mannino
- James F. DonohueJDJames F. Donohue
- Nicola A. HananiaNHNicola A. Hanania
- Catherine A. GrelletCGCatherine A. Grellet
- Alicia W. GilsenanAGAlicia W. Gilsenan
- Lori D. McLeodLMLori D. McLeod
- Anand A. DalalADAnand A. Dalal
- Ibrahim H. RaphiouIRIbrahim H. Raphiou
- Barbara A. PrillamanBPBarbara A. Prillaman
- Glenn D. CraterGCGlenn D. Crater
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 86 (5) , 375-381
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
This publication has 23 references indexed in Scilit:
- Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)Respiratory Medicine, 2010
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- The Effects of a Smoking Cessation Intervention on 14.5-Year MortalityAnnals of Internal Medicine, 2005
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003COPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
- Persistence of the Effect of the Lung Health Study (LHS) Smoking Intervention over Eleven YearsPreventive Medicine, 2002
- Smoking and Lung Function of Lung Health Study Participants after 11 YearsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- COPDChest, 2002
- The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States AdultsAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Obstructive Lung Disease and Low Lung Function in Adults in the United StatesArchives of internal medicine (1960), 2000
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994